DEXCOM INC (DXCM)
DEXCOM INC (DXCM) public financial performance, SEC filing summary, and valuation metrics.
Financial highlights
- Gross Profit: 750300000 usd (2026-03-31)
- Net Income: 199500000 usd (2026-03-31)
- Operating Income: 255300000 usd (2026-03-31)
- Contract Revenue: 1191900000 usd (2026-03-31)
- Operating Income: 911800000 usd (2025-12-31)
- Gross Profit: 2801900000 usd (2025-12-31)
- Contract Revenue: 4662000000 usd (2025-12-31)
- Net Income: 836300000 usd (2025-12-31)
- Contract Revenue: 1209300000 usd (2025-09-30)
- Operating Income: 242500000 usd (2025-09-30)
- Gross Profit: 731400000 usd (2025-09-30)
- Net Income: 283800000 usd (2025-09-30)
- Net Income: 179800000 usd (2025-06-30)
- Contract Revenue: 1157100000 usd (2025-06-30)
- Gross Profit: 688800000 usd (2025-06-30)
- Operating Income: 212600000 usd (2025-06-30)
- Net Income: 105400000 usd (2025-03-31)
- Gross Profit: 589000000 usd (2025-03-31)
- Contract Revenue: 1036000000 usd (2025-03-31)
- Operating Income: 133700000 usd (2025-03-31)
Valuation snapshot
- market cap: 33853030000
- pe ratio: 37.53556282